PMID- 29607391
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220408
IS  - 2364-3722 (Print)
IS  - 2196-9736 (Electronic)
IS  - 2196-9736 (Linking)
VI  - 6
IP  - 4
DP  - 2018 Apr
TI  - Perspectives on endoscopic submucosal dissection training in the United States: a 
      survey analysis.
PG  - E399-E409
LID - 10.1055/s-0044-101452 [doi]
AB  - BACKGROUND AND STUDY AIMS: Endoscopic submucosal dissection (ESD) is a widely 
      accepted method for en-bloc resection of dysplastic lesions and early cancer in 
      Asia and Europe. A limiting factor in adoption of ESD in the United States is 
      perceived lack of training opportunities. The aims of this study were to: (1) 
      evaluate ESD experience of attendees at a University-sponsored ESD training 
      course; (2) characterize effectiveness of the current ESD training regimen and 
      its impact on ESD adoption in the United States; and (3) gauge trainees' attitude 
      towards ESD. PATIENTS AND METHODS: An electronic anonymous survey was distributed 
      to the 86 physicians who participated in the University of Florida's annual ESD 
      course from 2014 to 2016. Main outcomes included participants' practice setting, 
      prior training, current ESD techniques, and planned training. RESULTS: A total of 
      34 participants (40 %) completed the survey. Most of the respondents routinely 
      use one or more endoscopic mucosal resection (EMR) techniques (97.1 %) in their 
      practice. Most respondents (79 %) had no experience with ESD on humans prior to 
      the ESD course. Following completion of course training, more participants 
      reported ongoing hands-on ESD exposure, with 15/34 (44 %) having performed ESD in 
      humans. Most participants identified potential hurdles for adoption of ESD. 
      CONCLUSION: A dedicated ESD training course with hands-on experience, under the 
      guidance of experts, notably increased use of ESD among participants. Limited 
      availability of structured training opportunities, concerns over procedural 
      length, lack of adequate number of lesions, and potential for serious adverse 
      events (AEs) were identified as the main factors slowing adoption of ESD in the 
      United States.
FAU - Schlachterman, Alexander
AU  - Schlachterman A
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University 
      of Florida, Gainesville, Florida, United States.
FAU - Yang, Dennis
AU  - Yang D
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University 
      of Florida, Gainesville, Florida, United States.
FAU - Goddard, April
AU  - Goddard A
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University 
      of Florida, Gainesville, Florida, United States.
FAU - Gotoda, Takuji
AU  - Gotoda T
AD  - Division of Gastroenterology and Hepatology, Department of Medicine Nihon 
      University School of Medicine, Tokyo, Japan.
FAU - Draganov, Peter V
AU  - Draganov PV
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University 
      of Florida, Gainesville, Florida, United States.
LA  - eng
PT  - Journal Article
DEP - 20180329
PL  - Germany
TA  - Endosc Int Open
JT  - Endoscopy international open
JID - 101639919
PMC - PMC5876020
COIS- Competing interests Dr. Draganov is a consultant for Boston Scientific, Cook 
      Medical, Olympus America, and Conmed. Dr. Yang is a consultant for US Endoscopy.
EDAT- 2018/04/03 06:00
MHDA- 2018/04/03 06:01
PMCR- 2018/04/01
CRDT- 2018/04/03 06:00
PHST- 2017/09/16 00:00 [received]
PHST- 2018/01/03 00:00 [accepted]
PHST- 2018/04/03 06:00 [entrez]
PHST- 2018/04/03 06:00 [pubmed]
PHST- 2018/04/03 06:01 [medline]
PHST- 2018/04/01 00:00 [pmc-release]
AID - 10.1055/s-0044-101452 [doi]
PST - ppublish
SO  - Endosc Int Open. 2018 Apr;6(4):E399-E409. doi: 10.1055/s-0044-101452. Epub 2018 
      Mar 29.